Chan-Eng Chong

Chan-Eng Chong

Auto-generated profile, based on publicly available information

Chan-Eng Chong

Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CHChristopher N Hahn
Christopher N Hahn
CCChan-Eng Chong
Chan-Eng Chong
CCCatherine L Carmichael
Catherine L Carmichael
EWElla J Wilkins
Ella J Wilkins
PBPeter J Brautigan
Peter J Brautigan
HSHamish S Scott
Hamish S Scott
Hamish Scott and colleagues report that germline mutations in GATA2 segregate with myelodysplastic syndrome and acute myeloid leukemia in four pedigrees. The resulting alterations occur in a conserved zinc finger DNA-binding domain of GATA2. We report the discovery of GATA2 as a new myelodysplastic syndrome (MDS)-acute myeloid leukemia (AML) predisposition gene. We found the same, previously unidentified heterozygous c.1061C>T (p.Thr354Met) missense mutation in the GATA2 transcription factor gene segregating with the multigenerational transmission of MDS-AML in three families and a GATA2 c.1063_1065delACA (p.Thr355del) mutation at an adjacent codon in a fourth MDS family. The resulting alterations reside within the second zinc finger of GATA2, which mediates DNA-binding and protein-protein interactions. We show differential effects of the mutations on the transactivation of target genes, cellular differentiation, apoptosis and global gene expression. Identification of such predisposing genes to familial forms of MDS and AML is critical for more effective diagnosis and prognosis, counseling, selection of related bone marrow transplant donors and development of therapies.

2 February 2012 in Blood
Verified
Journal Article
Open access
PDF file
JKJan Kazenwadel
Jan Kazenwadel
GSGenevieve A. Secker
Genevieve A. Secker
YLYajuan J. Liu
Yajuan J. Liu
JRJill A. Rosenfeld
Jill A. Rosenfeld
RWRobert S. Wildin
Robert S. Wildin
NHNatasha L. Harvey
Natasha L. Harvey
Recent work has established that heterozygous germline GATA2 mutations predispose carriers to familial myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML), “MonoMAC” syndrome, and DCML deficiency. Here, we describe a previously unreported MDS family carrying a missense GATA2 mutation (p.Thr354Met), one patient with MDS/AML carrying a frameshift GATA2 mutation (p.Leu332Thrfs*53), another with MDS harboring a GATA2 splice site mutation, and 3 patients exhibiting MDS or MDS/AML who have large deletions encompassing the GATA2 locus. Intriguingly, 2 MDS/AML or “MonoMAC” syndrome patients with GATA2 deletions and one with a frameshift mutation also have primary lymphedema. Primary lymphedema occurs as a result of aberrations in the development and/or function of lymphatic vessels, spurring us to investigate whether GATA2 plays a role in the lymphatic vasculature. We demonstrate here that GATA2 protein is present at high levels in lymphatic vessel valves and that GATA2 controls the expression of genes important for programming lymphatic valve development. Our data expand the phenotypes associated with germline GATA2 mutations to include predisposition to primary lymphedema and suggest that complete haploinsufficiency or loss of function of GATA2, rather than missense mutations, is the key predisposing factor for lymphedema onset. Moreover, we reveal a crucial role for GATA2 in lymphatic vascular development.

27 July 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JKJan Kazenwadel
Jan Kazenwadel
KBKelly L. Betterman
Kelly L. Betterman
CCChan-Eng Chong
Chan-Eng Chong
PSPhilippa H. Stokes
Philippa H. Stokes
YLYoung K. Lee
Young K. Lee
NHNatasha L. Harvey
Natasha L. Harvey
Heterozygous germline mutations in the zinc finger transcription factor GATA2 have recently been shown to underlie a range of clinical phenotypes, including Emberger syndrome, a disorder characterized by lymphedema and predisposition to myelodysplastic syndrome/acute myeloid leukemia (MDS/AML). Despite well-defined roles in hematopoiesis, the functions of GATA2 in the lymphatic vasculature and the mechanisms by which GATA2 mutations result in lymphedema have not been characterized. Here, we have provided a molecular explanation for lymphedema predisposition in a subset of patients with germline GATA2 mutations. Specifically, we demonstrated that Emberger-associated GATA2 missense mutations result in complete loss of GATA2 function, with respect to the capacity to regulate the transcription of genes that are important for lymphatic vessel valve development. We identified a putative enhancer element upstream of the key lymphatic transcriptional regulator PROX1 that is bound by GATA2, and the transcription factors FOXC2 and NFATC1. Emberger GATA2 missense mutants had a profoundly reduced capacity to bind this element. Conditional Gata2 deletion in mice revealed that GATA2 is required for both development and maintenance of lymphovenous and lymphatic vessel valves. Together, our data unveil essential roles for GATA2 in the lymphatic vasculature and explain why a select catalogue of human GATA2 mutations results in lymphedema.

25 February 2016 in Blood
Verified
Journal Article
Open access
PDF file
MLMaya Lewinsohn
Maya Lewinsohn
ABAnna L. Brown
Anna L. Brown
LWLuke M. Weinel
Luke M. Weinel
CPConnie Phung
Connie Phung
GRGeorge Rafidi
George Rafidi
HSHamish S Scott
Hamish S Scott
Key Points: Novel missense germ line DDX41 mutations define an earlier age of onset of hematologic malignancies than loss-of-function alleles. Carriers of DDX41 germ line mutations usually have normal blood counts until a myeloid or lymphoid malignancy develops.

1 January 2006 in In Silico Biology
Verified
Journal Article
Closed access
CCChan-Eng Chong
Chan-Eng Chong
BLBoon-San Lim
Boon-San Lim
SNSheila Nathan
Sheila Nathan
RMRahmah Mohamed
Rahmah Mohamed
Recent advances in DNA sequencing technology have enabled elucidation of whole genome information from a plethora of organisms. In parallel with this technology, various bioinformatics tools have driven the comparative analysis of the genome sequences between species and within isolates. While drawing meaningful conclusions from a large amount of raw material, computer-aided identification of suitable targets for further experimental analysis and characterization, has also led to the prediction of non-human homologous essential genes in bacteria as promising candidates for novel drug discovery. Here, we present a comparative genomic analysis to identify essential genes in Burkholderia pseudomallei. Our in silico prediction has identified 312 essential genes which could also be potential drug candidates. These genes encode essential proteins to support the survival of B. pseudomallei including outer-inner membrane and surface structures, regulators, proteins involved in pathogenenicity, adaptation, chaperones as well as degradation of small and macromolecules, energy metabolism, information transfer, central/intermediate/miscellaneous metabolism pathways and some conserved hypothetical proteins of unknown function. Therefore, our in silico approach has enabled rapid screening and identification of potential drug targets for further characterization in the laboratory.

21 June 2016 in Human Mutation
Verified
Journal Article
Closed access
PDF file
CBChristopher P. Barnett
Christopher P. Barnett
NNNathalie J. Nataren
Nathalie J. Nataren
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann
Quenten SchwarzQuenten Schwarz
Quenten Schwarz
CCChan-Eng Chong
Chan-Eng Chong
HSHamish S Scott
Hamish S Scott